Quick Answer
Wave Life Sciences Ltd. reported Common Stock Shares Outstanding of 187.66 million shares for the year ending 2025.
- Wave Life Sciences Ltd. showed an increase of +22.6% in Common Stock Shares Outstanding from 2024 to 2025.
- This data is from Wave Life Sciences Ltd.'s annual report (Form 10-K), filed with the SEC on February 26, 2026.
- XBRL data for this metric is available from 2014 to 2025 (12 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 12 years of available data (2014 to 2025), Wave Life Sciences Ltd.'s Common Stock Shares Outstanding has grown by 4,301.6%.
- Historical annual values: Fiscal year 2025: 187.66 million shares | Fiscal year 2024: 153.04 million shares | Fiscal year 2023: 119.16 million shares | Fiscal year 2022: 86.92 million shares | Fiscal year 2021: 59.84 million shares | Fiscal year 2020: 48.78 million shares | Fiscal year 2019: 34.34 million shares | Fiscal year 2018: 29.47 million shares | Fiscal year 2017: 27.83 million shares | Fiscal year 2016: 23.50 million shares | Fiscal year 2015: 21.55 million shares | Fiscal year 2014: 4.26 million shares.
- Data sourced from SEC EDGAR public filings as of June 23, 2026.
Last verified: